Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Clinical trial NCT02322736 · COMPLETED

Trial details

NCT number: NCT02322736
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Colorectal Cancer

Start date: 2014-11-21
Primary completion: 2018-08-03
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.